All these findings on PD-L1 and sPD-L1 are in accordance with our study: overexpression of sPD-L1 seems to characterize the more aggressive pancreatic tumors, as observed in our metastatic and relapsed patients. The gene discussed is SPDL1; the disease is pancreatic neoplasm.